DHD

Dược Vật tư Y tế Hải Dương ·UPCOM ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 8.29%, +1.56pp YoY
Price
28,600
Latest close
03 Jun 2026
P/E 17.38x
P/B 1.98x
EPS 1,646
BVPS 14,452
ROE 12.0%
ROA 6.9%
Profit Margin 8.3%
Asset Turnover 0.84x
Equity Mult. 1.73x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DHD is improving on both growth and profitability, painting a notably more positive picture versus the same period — profit is at an all-time high. When both scale and efficiency improve together, this is typically a sign of quality growth.

TTM REVENUE
VND 715bn
+5.3%YoY
NET MARGIN
8.29%
+1.6ppYoY
TTM NET PROFIT
VND 59bn
+29.6%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 192.2 196.1 164.6 162.1 160.9 183.5 160.6 174.2 146.6 165.8 139.0 128.5
Growth -2% +19% +2% +1% -12% +14% -8% +19% -12% +19% +8%
Net Income 16.9 17.6 13.0 11.9 13.3 11.8 10.5 10.1 8.1 7.8 8.2 7.1
Net Margin 8.79% 8.95% 7.88% 7.32% 8.27% 6.45% 6.57% 5.77% 5.54% 4.68% 5.89% 5.50%

Drivers of DHD's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 27.7bn
Administrative expenses ↑ 7.1bn
Tax ↑ 3.5bn
Selling expenses ↑ 3.3bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 5.9bn
Tax ↑ 0.9bn
Selling expenses ↑ 0.8bn
Administrative expenses ↑ 0.5bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 10.2% = 6.7% × 1.03 × 1.47
2026Q1 12.0% = 8.3% × 0.84 × 1.73

ROE rose from 10.2% to 12.0% — mainly driven by leverage, despite asset turnover moving in the opposite direction.

Net margin: 8.3% +1.6pp Asset turnover: 0.84x -0.20x Leverage: 1.73x +0.26x

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 8.29%, rising 1.6pp. Core operating signals are improving as Gross margin rose 2.2pp are enough to offset pressure from SG&A / Revenue rose 0.3pp (in addition, Net financial result / Revenue rose 0.1pp added support while Other profit / Revenue fell 0.1pp remained a drag).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin 8.29% +1.6pp
Gross Margin 35.16% +2.2pp
SG&A / Revenue 24.32% +0.3pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Is capital being deployed efficiently?

ROIC stands at 8.87%, broadly flat versus the same period. That translates to 8.87 in after-tax operating profit for every 100 units of operating capital. NOPAT margin rose 1.6pp, but capital turnover fell 0.27x, while invested capital expanded strongly by 156bn — the two factors are offsetting each other, keeping overall ROIC nearly unchanged.

Overall ROIC is flat while internal components are moving — watch which side becomes dominant in coming periods.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 8.87% +0.0pp
NOPAT Margin 8.13% +1.6pp
Capital Turnover 1.09x −0.27x
Average Invested Capital 655.5bn +155.9bn

Balance Sheet

Capital structure is conservative with low leverage — liabilities at 0.89x equity, net debt at 0.49x equity.

Inventory ended the period at 143.6bn, roughly 15.1% of total assets.

Over the last 12 months, working capital absorbed 8.1bn of cash, mainly because of higher inventories and lower payables. Part of that drag was offset by lower receivables.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables decreased → higher CFO: +32.9bn
Inventories increased → lower CFO: −15.2bn
Payables decreased → lower CFO: −25.9bn

Working Capital Efficiency

Cash conversion cycle lengthened by 3.8 days versus the same period last year. The main moves came from DIO rose 14.5 days, DSO rose 2.7 days, and DPO rose 13.5 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 117.5 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +2.7 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 64.0 days +2.7 days
Inventory 113.1 days +14.5 days
Payables 59.6 days +13.5 days
Cash Conversion Cycle 117.5 days +3.8 days

Is financial risk significant?

Leverage is safe but FCF is negative at 183.9bn due to capex of 265.2bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at 0.49x and interest coverage at 12.28x.

At present, short-term debt accounts for 22.9% of total debt, cash equals 16.5% of debt, and total debt stands at 307.3bn.

Watchpoints

Cash buffer is thin relative to debt

Cash / debt stands at 16.5%, leaving limited liquidity buffer to monitor.

Leverage and liquidity trend

Net Debt / Equity 0.49x +0.35x
Interest Coverage 12.28x +2.70x
Cash / Debt 16.5% −21.0pp
Short-term Debt / Total Debt 22.9% −36.5pp
CFO / NI 1.37x +1.17x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 55.7bn in 2025, against investing cash flow of -268.3bn.

Post-investment cash flow was negative +212.6bn. Financing cash flow was positive +225.8bn.

CFO / net income was 1.37x.

After spending +265.2bn on fixed-asset investment, the business generated trailing free cash flow of −183.9bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 81.3bn +72.0bn
Cash Capex 265.2bn +231.8bn
FCF TTM −183.9bn −159.8bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 1.6 pp. The main risk still sits in self-funded cash generation remains weak.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 8.29% after expanding 1.6pp versus the same period last year.

Key risk: self-funded cash generation remains weak, with trailing-12M FCF still at 183.9bn.

Statement Data

Item 2025 2024 2023 2022
Net Revenue
683.7 665.0 614.7 615.8
Cost of Goods Sold
438.7 454.8 426.7 442.9
Gross Profit
245.0 210.2 188.1 172.9
Financial Expenses
5.7 6.3 8.5 6.5
Selling Expenses
79.0 74.1 68.6 61.0
General and Administrative Expenses
93.2 81.8 72.7 69.1
Operating Profit
68.3 48.6 38.6 36.5
Profit Before Tax
69.8 50.8 39.5 37.8
Net Income
55.7 40.6 31.5 30.0
Profit Attributable to Parent
55.7 40.6 31.5 30.0
Earnings per Share
1,548.00 1,453.00 1,545.00 2,255.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.